Antiretroviral Activity and Safety of Once-Daily Etravirine in Treatment-Naive HIV-Infected Adults: 48-Week Results
Michelle Floris-Moore(University of North Carolina at Chapel Hill), Joseph J. Eron(University of North Carolina at Chapel Hill), Katie R. Mollan(University of North Carolina at Chapel Hill), Angela D. M. Kashuba(University of North Carolina at Chapel Hill), David A. Wohl(University of North Carolina at Chapel Hill), Marc A. Johnson(Carolinas Medical Center), Owen Francis(University of North Carolina at Chapel Hill), Aimee Wilkin(Wake Forest University), Kristine B. Patterson(University of North Carolina at Chapel Hill), Catherine Kronk(University of North Carolina at Chapel Hill)
Cited by 6
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Antiretroviral Treatment of Adult HIV Infection
|JAMA|2012|2.5k
Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy
|New England Journal of Medicine|1997|1.9k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k